Clinical Scorecard: Why Amyloid Gets It Wrong – and How CAP Plans to Set It Right

At a Glance

Key Highlights

• Standardized criteria for positive results are essential to ensure diagnostic reliability.

Guideline-Based Recommendations

Diagnosis

• Use well-standardized amyloid diagnostic panels validated across specimen types, such as FFPE and cytology.

Management

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Patients with suspected systemic amyloidosis requiring diagnostic evaluation.

Early detection can prevent the need for more invasive procedures.

Clinical Best Practices

• Integrate clinical findings and imaging studies with biopsy results for comprehensive patient assessment.

References

• College of American Pathologists Guidelines